Canary Speech Announces Presence Within Microsoft Booth at HIMSS

Strategic partnership with Microsoft provides growth opportunity for Canary Speech, which aims to set new industry standards for managing mental health and cognitive conditions

PROVO, Utah, Feb. 25, 2025 /PRNewswire/ — Canary Speech, Inc., a leader in AI-driven vocal biomarker technology, announced that they will be featured within the Microsoft Booth at this year’s HIMSS conference taking place from March 3rd-6th in Las Vegas.

Canary Speech, which aims to set new industry standards for managing mental health and cognitive conditions with their AI-driven vocal biomarker technology, entered into a strategic partnership with Microsoft last year. Canary Speech utilizes Microsoft Cloud for Healthcare, which allows them to strategically scale and grow their operations in regions including the U.S., Japan, U.K. and South America. Canary Speech also integrates with Microsoft Azure to allow healthcare organizations to purchase software subscriptions to Canary Speech to monitor patients for early disease detection and impairment.

“Microsoft’s commitment to working with partners is helping drive digital transformation in healthcare,” said Henry O’Connell, CEO and co-founder of Canary Speech. “The opportunities provided by Microsoft are helping us transform our business to deliver impactful, human-centered solutions. AI-enabled vocal biomarkers, powered by ambient listening, are revolutionizing healthcare by providing objective, real-time insights that enhance clinical decision-making,” said O’Connell. “At Canary Speech, we believe that voice is the next vital sign—empowering clinicians with cutting-edge tools to drive digital transformation and improve patient outcomes.”

Canary Speech credits its relationship with Microsoft for elevating its perspective on positioning for the future. Through advanced analysis using AI and machine learning techniques in speech biomarkers, Canary Speech’s proprietary technology enables a new approach to capturing and measuring critical data, which provides an alternative to today’s subjective behavioral health measurements.

“The future is conversational,” said Dr. Kathy VanEnkevort, industry leader of U.S. Health & Life Sciences at Microsoft. “With Canary Speech, we can further unlock the potential of the human voice in healthcare. By analyzing vocal biomarkers, we can gain valuable insights into an individual’s well-being, democratize access to expertise, and ultimately, arrest needless suffering.”

For more information about Canary Speech visit the Microsoft Booth #2221 located on Level 2 of The Venetian Convention & Expo Center, 201 Sands Avenue, Las Vegas or email info@canaryspeech.com.

About Canary Speech
Canary Speech is the leading AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Canary’s vocal biomarker technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression and dementia. Canary Speech is a Utah-based company that advances speech and language applications for health systems, payers and pharmaceutical markets.

Contacts
Caitlyn Brooksby
VP Marketing & Strategic Partnerships Canary Speech
caitlyn@canaryspeech.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/canary-speech-announces-presence-within-microsoft-booth-at-himss-302384168.html

SOURCE Canary Speech